±±¾©Èü³µpk10

The work is being carried out by Foviance in close partnership with Applied Works, AstraZeneca's creative agency.  Key objectives are to improve customer journey, while retaining brand values and creativity.

This marks a continued focus by the global company on web site improvement. AstraZeneca is currently the top pharmaceutical firm on the Bowen Craggs corporate web site index, and fifth overall.

Research will include testing prototype web sites on a sample of frequent users of AstraZeneca's sites. These are generally corporate, healthcare and patient audiences. The user sample will be assessed using eye-tracking tests and on their ability on predefined user tasks. This will inform  final design guidelines.

Sally Shackleton, corporate communications director for AstraZeneca, said: "AstraZeneca's reputation is driven by the experiences of our stakeholders, and it is always our goal to continually improve any point of contact. This is especially important online, where our web sites act as our window to the world.  We will be working with Foviance and Applied to review and improve our online customer experience, which will then be integrated into our web presence worldwide."